{"entity":{"type":"insider","cik":"0001418200","url":"/insider/0001418200","json_url":"/insider/0001418200.json","name":"Ricciardi Lisa","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":8,"n_filings":8,"first":"2008-11-25","last":"2026-04-20","span_basis":"filed_date"},"name_variants":[{"name":"Ricciardi Lisa","source":"filing","n_filings":8,"first_seen":"2008-11-25","last_seen":"2026-04-20"}],"transactions":[{"id":5821022,"accession":"0001104659-26-045502","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-26-045502","line_url":"/filing/0001104659-26-045502#line-1","is_derivative":false,"issuer_cik":"0001418200","issuer_name":"COGNITION THERAPEUTICS INC","issuer_ticker":"CGTX","issuer_name_source":null,"issuer_url":"/issuer/0001418200","owner_cik":"0001418200","owner_name":"Ricciardi Lisa","owner_url":"/insider/0001418200","role":"Director, Officer (CEO & President)","officer_title":"CEO & President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":9175.0,"shares_display":"9,175","price_per_share":1.1,"price_display":"1.10","price_state":"stated","total_value":10092.5,"total_display":"10,092.50","shares_owned_after":1715851.0,"shares_owned_after_display":"1,715,851","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-16","filed_date":"2026-04-20","scope":"insider"},{"id":4984979,"accession":"0001062993-25-001617","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-25-001617","line_url":"/filing/0001062993-25-001617#line-1","is_derivative":false,"issuer_cik":"0001418200","issuer_name":"COGNITION THERAPEUTICS INC","issuer_ticker":"CGTX","issuer_name_source":null,"issuer_url":"/issuer/0001418200","owner_cik":"0001418200","owner_name":"Ricciardi Lisa","owner_url":"/insider/0001418200","role":"Director, Officer (CEO & President)","officer_title":"CEO & President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":38851.0,"shares_display":"38,851","price_per_share":0.7722,"price_display":"0.77","price_state":"stated","total_value":30000.7422,"total_display":"30,000.74","shares_owned_after":38851.0,"shares_owned_after_display":"38,851","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-01-31","filed_date":"2025-02-04","scope":"insider"},{"id":2396672,"accession":"0001062993-24-006429","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-24-006429","line_url":"/filing/0001062993-24-006429#line-1","is_derivative":false,"issuer_cik":"0001418200","issuer_name":"COGNITION THERAPEUTICS INC","issuer_ticker":"CGTX","issuer_name_source":null,"issuer_url":"/issuer/0001418200","owner_cik":"0001418200","owner_name":"Ricciardi Lisa","owner_url":"/insider/0001418200","role":"Director, Officer (CEO & President)","officer_title":"CEO & President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5700.0,"shares_display":"5,700","price_per_share":1.75,"price_display":"1.75","price_state":"stated","total_value":9975.0,"total_display":"9,975.00","shares_owned_after":291345.0,"shares_owned_after_display":"291,345","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-14","filed_date":"2024-03-14","scope":"insider"},{"id":6239867,"accession":"0001062993-22-022243","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-22-022243","line_url":"/filing/0001062993-22-022243#line-1","is_derivative":false,"issuer_cik":"0001418200","issuer_name":"COGNITION THERAPEUTICS INC","issuer_ticker":"CGTX","issuer_name_source":null,"issuer_url":"/issuer/0001418200","owner_cik":"0001418200","owner_name":"Ricciardi Lisa","owner_url":"/insider/0001418200","role":"Director, Officer (CEO & President)","officer_title":"CEO & President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":12000.0,"shares_display":"12,000","price_per_share":1.3,"price_display":"1.30","price_state":"stated","total_value":15600.0,"total_display":"15,600.00","shares_owned_after":24500.0,"shares_owned_after_display":"24,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-15","filed_date":"2022-11-16","scope":"insider"},{"id":4282642,"accession":"0001104659-21-126362","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-126362","line_url":"/filing/0001104659-21-126362#line-1","is_derivative":false,"issuer_cik":"0001418200","issuer_name":"COGNITION THERAPEUTICS INC","issuer_ticker":"CGTX","issuer_name_source":null,"issuer_url":"/issuer/0001418200","owner_cik":"0001418200","owner_name":"Ricciardi Lisa","owner_url":"/insider/0001418200","role":"Director, Officer (CEO & President)","officer_title":"CEO & President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":12500.0,"shares_display":"12,500","price_per_share":12.0,"price_display":"12.00","price_state":"stated","total_value":150000.0,"total_display":"150,000.00","shares_owned_after":12500.0,"shares_owned_after_display":"12,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-13","filed_date":"2021-10-14","scope":"insider"},{"id":4564758,"accession":"0001209191-17-046321","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-046321","line_url":"/filing/0001209191-17-046321#line-1","is_derivative":false,"issuer_cik":"0001418200","issuer_name":"CONTRAFECT Corp","issuer_ticker":"CFRX","issuer_name_source":null,"issuer_url":"/issuer/0001418200","owner_cik":"0001418200","owner_name":"Ricciardi Lisa","owner_url":"/insider/0001418200","role":"Director","officer_title":null,"security_title":"Common Stock, par value $0.0001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":9600.0,"shares_display":"9,600","price_per_share":1.24,"price_display":"1.24","price_state":"stated","total_value":11904.0,"total_display":"11,904.00","shares_owned_after":9600.0,"shares_owned_after_display":"9,600","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-07-25","filed_date":"2017-07-26","scope":"insider"},{"id":8647686,"accession":"0001144204-15-030537","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-15-030537","line_url":"/filing/0001144204-15-030537#line-1","is_derivative":false,"issuer_cik":"0001117480","issuer_name":"CHIMERIX INC","issuer_ticker":"CMRX","issuer_name_source":null,"issuer_url":"/issuer/0001117480","owner_cik":"0001418200","owner_name":"Ricciardi Lisa","owner_url":"/insider/0001418200","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1950.0,"shares_display":"1,950","price_per_share":38.54,"price_display":"38.54","price_state":"stated","total_value":75153.0,"total_display":"75,153.00","shares_owned_after":1950.0,"shares_owned_after_display":"1,950","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-05-12","filed_date":"2015-05-14","scope":"insider"},{"id":3923018,"accession":"0001179110-08-020058","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-08-020058","line_url":"/filing/0001179110-08-020058#line-1","is_derivative":false,"issuer_cik":"0000877357","issuer_name":"SEPRACOR INC /DE/","issuer_ticker":"SEPR","issuer_name_source":null,"issuer_url":"/issuer/0000877357","owner_cik":"0001418200","owner_name":"Ricciardi Lisa","owner_url":"/insider/0001418200","role":"Director","officer_title":null,"security_title":"Sepracor Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4000.0,"shares_display":"4,000","price_per_share":11.85,"price_display":"11.85","price_state":"stated","total_value":47400.0,"total_display":"47,400.00","shares_owned_after":9000.0,"shares_owned_after_display":"9,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-11-24","filed_date":"2008-11-25","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":8,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":8,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":8},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001455365","name":"COGNITION THERAPEUTICS INC","url":"/issuer/0001455365","role":"Director, Officer (CEO & President)","n_filings":5,"first_seen":"2021-10-14","last_seen":"2026-04-20"},{"type":"issuer","type_label":"ISSUER","cik":"0001478069","name":"CONTRAFECT Corp","url":"/issuer/0001478069","role":"Director","n_filings":1,"first_seen":"2017-07-26","last_seen":"2017-07-26"},{"type":"issuer","type_label":"ISSUER","cik":"0001117480","name":"CHIMERIX INC","url":"/issuer/0001117480","role":"Director","n_filings":1,"first_seen":"2015-05-14","last_seen":"2015-05-14"},{"type":"issuer","type_label":"ISSUER","cik":"0000877357","name":"SEPRACOR INC /DE/","url":"/issuer/0000877357","role":"Director","n_filings":1,"first_seen":"2008-11-25","last_seen":"2008-11-25"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001418200","retrieved_at":"2026-08-21T08:11:14+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}